Biotech Profile
VERIGRAFT – First Industrially Scalable Personalised Tissue Therapy Platform Advances to Pivotal Phase II
Swedish biotech VERIGRAFT outlines how it solved regenerative medicine’s manufacturing paradox, creating the first tissue therapy platform designed for industrial-scale production while maintaining patient personalisation. Founded in Gothenburg in 2014, VERIGRAFT has achieved what many considered impossible in regenerative medicine: developing
12 September 2025